Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users

Analytical and Bioanalytical Chemistry

Volumn 400, Issue 1, 2011, Pages 145-152

  Toennes, Stefan W ^a   Schneider, Kirsten ^a   Kauert, Gerold F ^a   Wunder, Cora ^a   Moeller, Manfred R ^b   Theunissen, Eef L ^c   Ramaekers, Johannes G ^c  

^a GOETHE UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cannabis; Drug monitoring drug screening; Ethanol; Forensics toxicology; Interaction; Kinetics

Indexed keywords

BLOOD SAMPLES; BLOOD-ALCOHOL CONCENTRATION; CANNABIS; DRUG MONITORING/DRUG SCREENING; FORENSICS/TOXICOLOGY; ILLICIT DRUG; INTERACTION; PHARMACOKINETIC PARAMETERS; TIME WINDOWS;

BLOOD; CONCENTRATION (PROCESS); DRUG INTERACTIONS; PHARMACOKINETICS;

ETHANOL;

ALCOHOL; CANNABINOID; PLACEBO;

AREA UNDER THE CURVE; ARTICLE; BLOOD; CANNABIS SMOKING; HUMAN; MASS FRAGMENTOGRAPHY; METABOLISM; TISSUE DISTRIBUTION;

AREA UNDER CURVE; CANNABINOIDS; ETHANOL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MARIJUANA SMOKING; PLACEBOS; TISSUE DISTRIBUTION;

CANNABIS;

EID: 79954430362     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-010-4449-2     Document Type: Article

References (21)

1. EMCDDA Annual Report 2009: the state of the drugs problem in Europe (2009) European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal. http://www.emcdda.europa.eu/situation/cannabis/3, accessed 24 Sep 2010
2. Office of Applied Studies, SAMHSA, RTI International (2009) Concurrent illicit drug and alcohol use. The NSDUH Report March 19, 2009
3. M Koehm GF Kauert SW Toennes 2010 Influence of ethanol on the pharmacokinetics of methylphenidate's metabolites ritalinic acid and ethylphenidate Arzneimittelforschung 60 238 244 1:CAS:528:DC%2BC3cXot1Cnsbw%3D
4. M Perez-Reyes 1994 The order of drug administration: its effects on the interaction between cocaine and ethanol Life Sci 55 541 550 10.1016/0024- 3205(94)00747-0 1:CAS:528:DyaK2cXkvF2lu7c%3D
5. 6]ethanol: preliminary in vitro findings using a rat liver preparation J Pharm Sci 86 1494 1496 10.1021/js970072x 1:CAS:528:DyaK2sXnsFSisbY%3D (Pubitemid 28018334)
6. RA Dean CD Christian RH Sample WF Bosron 1991 Human liver cocaine esterases: ethanol-mediated formation of ethylcocaine FASEB J 5 2735 2739 1:CAS:528:DyaK3MXmt1egsLw%3D (Pubitemid 21905827)
7. M Linnoila MJ Mattila BS Kitchell 1979 Drug interactions with alcohol Drugs 18 299 311 10.2165/00003495-197918040-00003 1:CAS:528:DyaL3cXjvQ%3D%3D (Pubitemid 10239187)
8. EA Lane S Guthrie M Linnoila 1985 Effects of ethanol on drug and metabolite pharmacokinetics Clin Pharmacokinet 10 228 247 10.2165/00003088- 198510030-00003 1:CAS:528:DyaL2MXlvVyru70%3D (Pubitemid 15093448)
9. M Perez-Reyes RE Hicks J Bumberry AR Jeffcoat CE Cook 1988 Interaction between marihuana and ethanol: effects on psychomotor performance Alcohol Clin Exp Res 12 268 276 10.1111/j.1530-0277.1988.tb00193.x 1:CAS:528: DyaL1cXhvF2lsr8%3D
10. SE Lukas S Orozco 2001 Ethanol increases plasma delta(9)- tetrahydrocannabinol (THC) levels and subjective effects after marihuana smoking in human volunteers Drug Alcohol Depend 64 143 149 10.1016/S0376-8716(01)00118- 1 1:CAS:528:DC%2BD3MXmsFemurg%3D (Pubitemid 32816957)
11. SE Lukas R Benedikt JH Mendelson E Kouri M Sholar L Amass 1992 Marihuana attenuates the rise in plasma ethanol levels in human subjects Neuropsychopharmacology 7 77 81 1:CAS:528:DyaK38XmtVKmsL4%3D
12. NL Benowitz RT Jones 1977 Effects of delta-9-tetrahydrocannabinol on drug distribution and metabolism. Antipyrine, pentobarbital, and ethanol Clin Pharmacol Ther 22 259 268 1:CAS:528:DyaE2sXlvFemtrw%3D (Pubitemid 8151108)
13. Ramaekers JG, Theunissen EL, Brouwer M de, Toennes SW, Moeller MR, Kauert G (2010) Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology (Berl) (in press)
14. JG Ramaekers G Kauert P van Ruitenbeek EL Theunissen E Schneider MR Moeller 2006 High-potency marijuana impairs executive function and inhibitory motor control Neuropsychopharmacology 31 2296 2303 1:CAS:528: DC%2BD28Xps1WhsLY%3D (Pubitemid 44413210)
15. SW Toennes JG Ramaekers EL Theunissen MR Moeller GF Kauert 2008 Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint J Anal Toxicol 32 470 477 1:CAS:528:DC%2BD1cXps1eks74%3D
16. GF Kauert JG Ramaekers E Schneider MR Moeller SW Toennes 2007 Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid J Anal Toxicol 31 288 293 1:CAS:528:DC%2BD2sXmt1GmsL4%3D (Pubitemid 46911627)
17. F Grotenhermen 2003 Pharmacokinetics and pharmacodynamics of cannabinoids Clin Pharmacokinet 42 327 360 10.2165/00003088-200342040-00003 1:CAS:528:DC%2BD3sXjsFWis7g%3D (Pubitemid 36433875)
18. J Mendelson RT Jones R Upton P Jacob 1995 Methamphetamine and ethanol interactions in humans Clin Pharmacol Ther 57 559 568 10.1016/0009-9236(95) 90041-1 1:CAS:528:DyaK2MXmsVGqs7s%3D
19. EL Karschner EW Schwilke RH Lowe WD Darwin RI Herning JL Cadet MA Huestis 2009 Implications of plasma delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers J Anal Toxicol 33 469 477 1:CAS:528:DC%2BD1MXht1yntbbK
20. A Glaz-Sandberg L Dietz H Nguyen H Oberwittler R Aderjan G Mikus 2007 Pharmacokinetics of 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol (CTHC) after intravenous administration of CTHC in healthy human subjects Clin Pharmacol Ther 82 63 69 10.1038/sj.clpt.6100199 1:CAS:528:DC%2BD2sXotVGju7c%3D (Pubitemid 46944196)
21. F Musshoff B Madea 2006 Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use Ther Drug Monit 28 155 163 10.1097/01.ftd.0000197091.07807.22 1:CAS:528:DC%2BD28Xjs1Kku70%3D (Pubitemid 44314942)